Cargando…

Comprehensive molecular profiling of lung adenocarcinoma

Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report molecular profiling of 230 resected lung adenocarcinomas using messenger RNA, microRNA and DNA sequencing integrated with copy number, methylation and proteomic analyses. High rates of somatic mutation were see...

Descripción completa

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231481/ https://www.ncbi.nlm.nih.gov/pubmed/25079552 http://dx.doi.org/10.1038/nature13385

Ejemplares similares

Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors
por: Klotz, Laura V., et al.
Publicado: (2019)

Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component
por: Suzuki, Masaki, et al.
Publicado: (2021)

Comprehensive Proteomic Profiling of Aldehyde Dehydrogenases in Lung Adenocarcinoma Cell Lines
por: Zhang, Qing, et al.
Publicado: (2011)

Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma
por: Li, Chang, et al.
Publicado: (2021)

Comprehensive molecular characterization of gastric adenocarcinoma
Publicado: (2014)

A Comprehensive Peptidome Profiling Technology for the Identification of Early Detection Biomarkers for Lung Adenocarcinoma
por: Ueda, Koji, et al.
Publicado: (2011)

Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2022)

Comprehensive review of fetal adenocarcinoma of the lung
por: Ricaurte, Luisa María, et al.
Publicado: (2018)

Comprehensive Analysis of Circular RNA Expression Profiles in Gefitinib-Resistant Lung Adenocarcinoma Patients
por: Zou, Junyong, et al.
Publicado: (2022)

Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Zengin, Talip, et al.
Publicado: (2021)

Assessing Oncologists’ Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil
por: Fares, Aline F., et al.
Publicado: (2022)

A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients
por: Zhang, Xilin, et al.
Publicado: (2020)

Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma
por: Lin, Guofu, et al.
Publicado: (2021)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

Comprehensive analysis of age‐related somatic mutation profiles in Chinese young lung adenocarcinoma patients
por: Yang, Bo, et al.
Publicado: (2019)

Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma
por: Qiu, Mantang, et al.
Publicado: (2016)

Comprehensive circular RNA expression profile of lung adenocarcinoma with bone metastasis: Identification of potential biomarkers
por: Cai, Ying, et al.
Publicado: (2022)

Comprehensive Profiling of lincRNAs in Lung Adenocarcinoma of Never Smokers Reveals Their Roles in Cancer Development and Prognosis
por: Li, Ying, et al.
Publicado: (2017)

Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma
por: Bao, Guangyao, et al.
Publicado: (2022)

Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
por: Wang, Yufei, et al.
Publicado: (2022)

Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
por: Kuang, Junjie, et al.
Publicado: (2023)

Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration
por: Hu, Kuan, et al.
Publicado: (2021)

Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
por: Quintanal-Villalonga, Alvaro, et al.
Publicado: (2021)

Comprehensive molecular characterizations of stage I–III lung adenocarcinoma with tumor spread through air spaces
por: Ye, Ronghao, et al.
Publicado: (2023)

Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma
por: Pan, Meini, et al.
Publicado: (2023)

Advanced Lung Adenocarcinoma Patient with ERBB2 Amplification Identified by Comprehensive Genomic Profiling Benefits from Trastuzumab
por: Tao, Chi-Wei, et al.
Publicado: (2020)

Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma
por: Xiang, Chan, et al.
Publicado: (2022)

Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma
por: Li, Fangfang, et al.
Publicado: (2022)

Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models
por: Peinado, Paola, et al.
Publicado: (2020)

Identification of potential prognostic markers for lung adenocarcinoma using comprehensive analysis
por: Huang, Liang, et al.
Publicado: (2023)

Adequacy of pleural fluid cytology for comprehensive molecular analysis of lung adenocarcinoma: Experience of a large health-care system
por: Dalvi, Siddhartha Dilip, et al.
Publicado: (2022)

The comprehensive investigation of transcription factor AP-2 alpha in lung adenocarcinoma
por: Liao, Hongli, et al.
Publicado: (2020)

Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma
por: Lin, Zhimin, et al.
Publicado: (2023)

Comprehensive molecular profiling of pulmonary pleomorphic carcinoma
por: Nagano, Masaaki, et al.
Publicado: (2021)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

Molecular features of lung adenocarcinoma in young patients
por: Chen, Zhen, et al.
Publicado: (2019)

Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma
por: Ötvös, Rita, et al.
Publicado: (2015)

Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic
por: Freitas, Helano C., et al.
Publicado: (2020)

The transcriptional landscape and mutational profile of lung adenocarcinoma
por: Seo, Jeong-Sun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gb7fm5jeundfpjj9snqo1g6tfr